文献速递新生儿儿童感染

新生儿早发型脓毒症计算器与减少抗生素治疗及安全性的关联:系统综述与荟萃分析

Association of Use of the Neonatal Early-Onset Sepsis Calculator With Reduction in Antibiotic Therapy and Safety: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Pediatr · 2019-01-01

所有研究均发现EOS计算器组经验性抗生素治疗相对风险更低(范围3%-60%),荟萃分析显示前后对照研究中抗生素使用相对风险为56%(95%CI 53%-59%)。安全性证据有限,但EOS计算器组与传统管理策略的漏诊EOS比例相当(5/18 [28%] vs 8/28 [29%];合并OR 0.96,95%CI 0.26-3.52;

要点

  • EOS计算器指导管理可大幅降低疑似EOS新生儿的经验性抗生素使用。
  • 安全性证据有限,但漏诊EOS比例与传统管理策略相当。
  • 临床实施EOS计算器需结合当地条件并持续监测安全性。

核心结论

  • 使用新生儿EOS计算器与疑似EOS新生儿经验性抗生素使用大幅减少相关。
  • 现有安全性证据有限,但未显示EOS计算器管理劣于传统管理策略。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Embase、Web of Science和Google Scholar从2011年至2019年1月31日。
  • 采用PRISMA-P指南提取数据,使用CHARMS和GRADE工具评估偏倚风险与证据质量,对独立队列研究进行随机效应模型荟萃分析。

主要发现

  • 所有研究均发现EOS计算器组经验性抗生素治疗相对风险更低(范围3%-60%)。
  • 荟萃分析显示,在纳入无论是否暴露于绒毛膜羊膜炎的新生儿的前后对照研究中,抗生素使用相对风险为56%(95%CI 53%-59%)。

临床怎么用

  • 对于疑似EOS新生儿,可考虑采用EOS计算器辅助决策以减少不必要的经验性抗生素使用。
  • 实施EOS计算器时应建立安全性监测机制,关注漏诊EOS、再入院、治疗延迟、发病率和死亡率。

局限性

  • 安全性证据有限,相关结局数据不足。
  • 纳入研究多为前后对照设计,可能存在偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The neonatal early-onset sepsis (EOS) calculator is a clinical risk stratification tool increasingly used to guide the use of empirical antibiotics for newborns. Evidence on the effectiveness and safety of the EOS calculator is essential to inform clinicians considering implementation. OBJECTIVE: To assess the association between management of neonatal EOS guided by the neonatal EOS calculator (compared with conventional management strategies) and reduction in antibiotic therapy for newborns. DATA SOURCES: Electronic searches in MEDLINE, Embase, Web of Science, and Google Scholar were conducted from 2011 (introduction of the EOS calculator model) through January 31, 2019. STUDY SELECTION: All studies with original data that compared management guided by the EOS calculator with conventional management strategies for allocating antibiotic therapy to newborns suspected to have EOS were included. DATA EXTRACTION AND SYNTHESIS: Following PRISMA-P guidelines, relevant data were extracted from full-text articles and supplements. CHARMS (Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies) and GRADE (Grades of Recommendation, Assessment, Development and Evaluation) tools were used to assess the risk of bias and quality of evidence. Meta-analysis using a random-effects model was conducted for studies with separate cohorts for EOS calculator and conventional management strategies. MAIN OUTCOMES AND MEASURES: The difference in percentage of newborns treated with empirical antibiotics for suspected or proven EOS between management guided by the EOS calculator and conventional management strategies. Safety-related outcomes involved missed cases of EOS, readmissions, treatment delay, morbidity, and mortality. RESULTS: Thirteen relevant studies analyzing a total of 175 752 newborns were included. All studies found a substantially lower relative risk (range, 3%-60%) for empirical antibiotic therapy, favoring the EOS calculator. Meta-analysis revealed a relative risk of antibiotic use of 56% (95% CI, 53%-59%) in before-after studies including newborns regardless of exposure to chorioamnionitis. Evidence on safety was limited, but proportions of missed cases of EOS were comparable between management guided by the EOS calculator (5 of 18 [28%]) and conventional management strategies (8 of 28 [29%]) (pooled odds ratio, 0.96; 95% CI, 0.26-3.52; P = .95). CONCLUSIONS AND RELEVANCE: Use of the neonatal EOS calculator is associated with a substantial reduction in the use of empirical antibiotics for suspected EOS. Available evidence regarding safety of the use of the EOS calculator is limited, but shows no indication of inferiority compared with conventional management strategies.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Achten NB, Klingenberg C, Benitz WE, et al. Association of Use of the Neonatal Early-Onset Sepsis Calculator With Reduction in Antibiotic Therapy and Safety: A Systematic Review and Meta-analysis. JAMA Pediatr. 2019. PMID: 31479103. doi:10.1001/jamapediatrics.2019.2825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。